## MTD: Mettler-Toledo International, I - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -2.6% below STRENGTH zone (3.0-6.0%); PEG 3.64 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-6.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1372.42)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Mettler-Toledo International, Inc. $MTD Shares Acquired by Korea Investment CORP**
- Source: MarketBeat | 20251201T112202 | Somewhat-Bullish | Relevance: 99%
- Korea Investment CORP significantly increased its stake in Mettler-Toledo International, Inc. (MTD) by 21.3% in Q2, acquiring an additional 2,845 shares. This investment positions Korea Investment CORP as a notable holder with 16,202 shares valued at approximately $19.03 million. The article also details Mettler-Toledo's strong Q3 earnings, beating expectations with $11.15 EPS and $1.03 billion in revenue, alongside insider trading activities and recent analyst ratings.

**2. BLI Banque de Luxembourg Investments Sells 900 Shares of Mettler-Toledo International, Inc. $MTD**
- Source: MarketBeat | 20251130T083702 | Neutral | Relevance: 99%
- BLI Banque de Luxembourg Investments reduced its stake in Mettler-Toledo International, Inc. by selling 900 shares, bringing its total holdings to 8,000 shares valued at $9.47 million. Other institutional investors also adjusted their positions, and the company's stock experienced a slight dip despite reporting strong quarterly earnings that beat analyst estimates. Insider selling by CEO Patrick Kaltenbach and Gerry Keller was also noted, alongside updated price targets from several Wall Street analysts.

**3. Skandinaviska Enskilda Banken AB publ Sells 2,577 Shares of Mettler-Toledo International, Inc. $MTD**
- Source: MarketBeat | 20251202T113248 | Neutral | Relevance: 99%
-  Skandinaviska Enskilda Banken AB publ has reduced its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 29.7%, selling 2,577 shares and now owning 6,103 shares valued at approximately $7.17 million. This transaction comes amidst other institutional investor activity and recent insider selling, including CFO Shawn Vadala and Director Elisha W. Finney. Mettler-Toledo reported strong quarterly earnings, beating EPS estimates, and has a market capitalization of $30.17 billion.

**4. Loomis Sayles & Co. L P Buys 12,671 Shares of Mettler-Toledo International, Inc. $MTD**
- Source: MarketBeat | 20251130T115126 | Neutral | Relevance: 98%
- Loomis Sayles & Co. L P increased its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 7.7%, purchasing an additional 12,671 shares. This brings their total holdings to 178,128 shares valued at approximately $209.3 million, representing 0.86% of the company. The article also details recent insider selling by the CEO and CFO, as well as updated analyst ratings and the company's strong financial performance.

**5. Mettler-Toledo International, Inc. $MTD Shares Sold by Schroder Investment Management Group**
- Source: MarketBeat | 20251202T120345 | Neutral | Relevance: 98%
- Schroder Investment Management Group reduced its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 12.7% in Q2 2025, selling 6,397 shares but still holding 43,989 shares valued at $51.7 million, while institutional investors combined own 95.07% of the company. Mettler-Toledo exceeded Q3 earnings estimates with an EPS of $11.15 and revenue of $1.03 billion, and analysts currently have a "Hold" rating on the stock with a $1,406.50 target price. Company insiders have also been net sellers, with the CEO and CFO collectively disposing of 3,000 shares recently, contributing to 19,565 shares worth about $28.68 million sold by insiders over the last 90 days.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Goldman Sachs | $1475 | $0 | 0% |
| 2025-12-02 | Morgan Stanley | $1550 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Goldman Sachs | init | Neutral |
| 2025-12-02 | Morgan Stanley | init | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 18 ($1.28M) |
| Sells | 6 ($0.98M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (+1.4%)
- Blackrock Inc.: 9.2% (-3.1%)
- State Street Corpora: 4.7% (-0.5%)
- Capital Internationa: 4.2% (+1.2%)
- Bank Of New York Mel: 4.0% (-9.0%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.64 signals overvaluation risk, limited margin of safety. Forward P/E 31.6x stretched relative to 8% growth. Quality metrics strong (ROE 30%, ROA 20%, margin 21%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $29.0B |
| Beta | 1.40 |
| 52W Range | $946.69 - $1525.17 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.64 |
| Forward P/E | 31.6 |
| Current P/E | 34.3 |
| YoY Growth | 8.4% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 4.0% to -2.6% (-6.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.7pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 55.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.65% (CS: 27) | Weak |
| RSI_14 | 55.0 | Neutral |
| MACD Histogram | 0.02 | Bullish |
| vs SMA20 | 1.006x | Above |
| vs SMA50 | 1.055x | Above |
| vs SMA200 | 1.167x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1447.16
- **Stop Loss:** $1372.42 (5.2% risk)
- **Target:** $1521.90 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 13
- **Position Value:** $18,813.08
- **Portfolio %:** 18.81%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-05 (Est: $12.80)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $10.66 | $11.15 | +4.6% |
| 2025Q2 | $9.60 | $10.09 | +5.1% |
| 2025Q1 | $7.88 | $8.19 | +3.9% |
| 2024Q4 | $11.72 | $12.41 | +5.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*